White Label Skincare Agreements in the UK

A white label skincare arrangement can get your cleanser, serum or moisturiser to market quickly, but the contract behind it needs to do more than confirm price and delivery. Common mistakes include assuming the manufacturer owns all compliance tasks, using product claims the formula cannot support, and failing to secure rights to your branding or modified formulation.

For a founder placing a first purchase order, the legal issues can feel hidden until something goes wrong: a failed stability test, a packaging error, a delayed batch, a customer reaction, or a retailer asking for product safety documents. A well drafted white label skincare agreement should tell you who controls the formula, who keeps batch records, who handles notifications and recalls, and what happens if supply stops.

The aim is to make the relationship commercially clear from day one, especially where your brand reputation depends on a third party's manufacturing, labelling and compliance processes.

What a White Label Skincare Agreement Should Cover

A white label skincare agreement should set out the commercial deal, the product specification, compliance responsibilities, quality standards, IP rights and supply obligations in one clear contract. A basic set of product supply terms is rarely enough for a skincare brand because cosmetics carry product safety, labelling, claims and traceability requirements.

In a typical white label model, the manufacturer already has a base product or catalogue formula. Your brand chooses the product, may request adjustments to fragrance, actives, texture, packaging or label design, and sells the finished product under your own name. A private label skincare contract works in a similar way, although some businesses use private label to describe more customised products.

The contract, and any agreed heads of terms, should match the actual working relationship. If the supplier is only filling a standard product into your packaging, you need different manufacturing terms from a brand co-developing a new formulation with a chemist and then scaling production. The more control you have over claims, packaging and distribution, the more carefully the agreement should allocate risk.

Core commercial terms usually include:

• Product description: the exact products, SKUs, sizes, ingredients, fragrance options, packaging components and approved specifications.
• Ordering process: purchase orders, lead times, minimum order quantities, batch sizes, forecast requirements and acceptance of orders.
• Pricing: unit costs, set-up fees, artwork charges, testing costs, storage fees, price review rights and VAT treatment.
• Delivery: delivery location, Incoterms if relevant, import or export documents, risk transfer, title transfer, delays and split shipments.
• Payment: deposits, balance payments, credit terms, late payment consequences and whether production begins only after payment.
• Change control: how formula, packaging, ingredient or label changes are requested, approved and priced.
• Exclusivity: whether your brand has exclusive access to a product, formula, fragrance or packaging format, and for how long.
• Term and termination: contract length, renewal, minimum commitments, termination rights and the effect on remaining stock.

A practical contract also deals with the moments founders often forget during launch planning. For example, if a retailer requests evidence of a Cosmetic Product Safety Report, does the manufacturer supply it directly, or does your brand maintain the Product Information File? If a packaging supplier delivers defective pumps, who pays for rework? If a TikTok campaign causes demand to spike, is the manufacturer obliged to prioritise your next batch?

For UK brands, the contract should sit alongside your wider compliance documents, such as your website terms, consumer returns process, privacy documents, retailer terms and advertising approvals. Those documents do different jobs, but they should not contradict the manufacturing terms.

Formula Ownership, Branding and IP Rights

The agreement should clearly say who owns the base formula, any customised developments, the product name, packaging artwork and confidential know-how. Without clear IP terms, both parties may leave the relationship with different assumptions about what can be reused.

White label skincare often starts with the supplier's existing formula. In that case, the manufacturer will usually retain ownership of the base formula and manufacturing know-how. Your brand receives a right to buy finished goods and sell them under your branding. That may be workable, but it means a competitor may be able to buy a similar product unless you negotiate exclusivity.

If you pay for development work, the position should be more specific. You may expect to own a bespoke formula because you funded testing, selected ingredients and directed the concept. The supplier may say its chemists created the formulation and that your fee only covered development time. A contract should answer this before work starts.

Key IP and confidentiality points include:

• Base formula rights: whether the manufacturer can continue using the original formula for other customers.
• Customisation rights: who owns changes to actives, fragrance, colour, viscosity, preservative systems or packaging compatibility work.
• Brand assets: confirmation that your business owns your brand name, logo, label artwork, product photography and marketing copy, unless a designer or agency owns part of it.
• Trade marks: responsibility for checking and registering product names or brand names with the UK Intellectual Property Office.
• Confidential information: protection for formulas, supplier pricing, launch plans, retailer lists, customer data, testing data and product roadmaps.
• Reverse engineering: limits on either party analysing, copying or recreating confidential formulations outside the agreed project.
• Portfolio use: whether the manufacturer can name your brand as a client or show your product in case studies.

Exclusivity deserves special attention. A brand may think it has an exclusive white label product because the packaging looks distinctive, but the supplier may still sell the same bulk formulation to other brands with different labels. If exclusivity matters, define exactly what is exclusive. It could apply to a formula, ingredient combination, fragrance, packaging format, target market, retail channel or territory.

For example, your agreement might say the manufacturer cannot supply the same niacinamide gel moisturiser formulation to another UK skincare brand for 18 months, provided your brand meets agreed order volumes. The manufacturer may resist open-ended exclusivity unless you commit to minimum purchases. A volume-based arrangement can be a fair middle ground.

Your contract should also control changes to the formula. A supplier may need to change an ingredient because of availability, cost, safety updates or regulatory changes. Even a small substitution can affect texture, allergens, product claims, shelf life or customer experience. The agreement should require notice and written approval for material changes, together with any necessary testing, document updates and label changes.

Brand protection also extends to your marketing. If your manufacturer prepares product descriptions or suggested claims, your business still needs the right to edit, approve and reject those materials. You should not be locked into using claims that are unsupported, too broad or inconsistent with your brand positioning.

UK Cosmetics Compliance, Claims and Responsible Person Duties

A cosmetics manufacturing agreement in the UK should allocate legal responsibility for safety assessments, product information files, notifications, labelling and claims substantiation. The manufacturer may handle much of the technical work, but your brand can still carry commercial and regulatory risk once the product is sold under your name.

Cosmetic products placed on the market in Great Britain must comply with the UK cosmetics regime, including requirements derived from Regulation (EC) No 1223/2009 as retained and amended in UK law. The Office for Product Safety and Standards is the national regulator for product safety matters. Northern Ireland can involve additional requirements because EU cosmetics rules may apply under post-Brexit arrangements, so brands selling UK-wide should confirm the correct route for each market.

A central concept is the Responsible Person. Each cosmetic product must have a Responsible Person established in the relevant market. The Responsible Person is responsible for ensuring key compliance obligations are met, including safety assessment, product information, notification and labelling. In some white label arrangements, the manufacturer or an appointed compliance provider acts as Responsible Person. In others, the brand takes that role.

Your agreement should identify:

• who is the Responsible Person for Great Britain, and if relevant, Northern Ireland or the EU;
• who prepares and maintains the Cosmetic Product Safety Report;
• who keeps the Product Information File and for how long;
• who submits notifications through the relevant UK notification portal, such as the Submit Cosmetic Product Notifications service for Great Britain;
• who checks labels for mandatory information, warnings, allergens, nominal content, batch number and responsible person details;
• who confirms Good Manufacturing Practice, often by reference to ISO 22716 or equivalent processes;
• who monitors ingredient restrictions, banned substances and regulatory changes; and
• who responds to regulator requests and customer safety complaints.

Product claims are another high-risk area for skincare brands. Claims such as anti-ageing, brightening, barrier repair, dermatologist tested, organic, natural, clinically proven, pregnancy safe, acne reducing or eczema friendly can trigger evidence requirements and advertising scrutiny. Some claims may also risk moving the product towards medicinal claims if they suggest treating or preventing disease.

The Advertising Standards Authority can consider complaints about marketing claims under the CAP Code. The Digital Markets, Competition and Consumers Act 2024, the Consumer Rights Act 2015 and the CAP Code are also relevant to misleading selling practices, consumer expectations and advertising claims. The Consumer Protection from Unfair Trading Regulations 2008 may still matter for conduct before 6 April 2025 under transitional saving arrangements. If your marketing says a product does something, you need evidence that supports the claim in the way consumers are likely to understand it.

The agreement should therefore state who approves claims and what evidence is required. A practical clause might require the manufacturer to provide technical substantiation for claims it proposes, while your brand remains responsible for final advertising copy, influencer briefs, website descriptions and retail listings. If the manufacturer has not tested a claim, the contract should stop either party presenting it as verified.

Common claim issues include:

• Overstated results: using wording such as eliminates wrinkles or cures acne when the evidence only supports a milder cosmetic effect.
• Ingredient halo claims: suggesting the finished product has a proven effect because one ingredient has been studied separately.
• Natural or clean beauty claims: making broad environmental or safety claims without clear definitions and proof.
• Testing claims: using clinically proven, dermatologist approved or hypoallergenic without suitable evidence and records.
• Before and after content: publishing user images without clear consent, accurate presentation and claim substantiation.

Data protection may also arise. If the manufacturer helps investigate adverse reactions and receives customer names, photos, medical details or contact information, UK GDPR and the Data Protection Act 2018 may apply. Your contract should say whether the supplier acts as a processor or independent controller for any personal data, what data can be shared, and how safety information is protected.

Batch Records, Quality Control, Recalls and Supply Issues

A strong skincare supplier agreement should make traceability and quality obligations operational, not just aspirational. When a batch problem occurs, you need access to records, clear testing standards and a process for pausing sales or recalling products.

Cosmetics are batch-based products. One production run may have a different ingredient lot, operator, filling line, packaging batch or storage condition from another. If customers report irritation or separation in a serum, batch records help identify whether the issue is isolated or wider. They are also essential for regulator enquiries and retailer investigations.

Your agreement should require the manufacturer to keep records such as:

• batch numbers and manufacturing dates;
• ingredient lot numbers and certificates of analysis where available;
• production records, filling records and packaging line checks;
• quality control test results and release approvals;
• stability, compatibility or challenge test reports where relevant;
• deviation reports and corrective actions;
• retained samples from each batch; and
• complaint and adverse event records linked to the product.

The contract should say when your brand can access these records. Manufacturers may resist handing over confidential manufacturing data, especially for white label formulas. A balanced position is to require enough information for compliance, recall handling, retailer due diligence and safety investigations, while protecting trade secrets.

Quality control terms should define what counts as an acceptable product. For skincare, quality may cover appearance, odour, colour, viscosity, pH, fill volume, packaging integrity, label placement, seal quality, contamination limits and compliance with the approved specification. The agreement should also state how and when goods are inspected, and what happens if defects are found after delivery.

Consider a founder who receives 5,000 units of a moisturiser two weeks before a retail launch. The outer cartons look fine, but 20 percent of pumps leak during shipping. If the contract only says the supplier will deliver goods, the dispute may become messy. Better terms would cover packaging tests, acceptance criteria, rejection rights, replacement timelines, credit notes, rework costs and responsibility for urgent freight.

Recall clauses are especially important because skincare brands sell directly to consumers, retailers, salons, clinics, marketplaces and subscription boxes. A recall may be needed because of contamination, mislabelling, undeclared allergens, incorrect batch coding, packaging failure or an ingredient issue. The agreement should identify who decides whether to recall, who notifies regulators or retailers, who pays, and who manages customer communications.

A recall process should cover:

• immediate notification of suspected safety or quality issues;
• quarantine of affected stock at the manufacturer, brand warehouse and retailer locations;
• sharing of batch records, test results and complaint data;
• decision-making authority for withdrawals, recalls or corrective actions;
• consumer notices, retailer scripts and marketplace communications;
• refunds, replacements, disposal, rework and transport costs;
• insurance notifications and evidence preservation; and
• post-incident review to prevent repeat issues.

Supply continuity is another commercial pressure point. White label brands often build marketing calendars around product drops, influencer campaigns and seasonal launches. If the supplier cannot obtain a key ingredient or packaging component, your launch can stall. Your agreement should deal with forecasting, stock reservations, substitute materials, delay notices and whether you can use another manufacturer if supply fails.

White label manufacturing terms should also address end-of-relationship issues. If the contract ends, can you buy remaining packaging and labels? Can you place a final order? Will the manufacturer continue supplying for a transition period? Will it transfer documents needed for compliance? These details can determine whether your brand has a smooth exit or loses months rebuilding a product line.

Insurance and liability should be realistic. The manufacturer should usually carry appropriate product liability and public liability cover, and your brand should consider its own cover for product sales and recall costs. The contract can require evidence of insurance, but insurance should not replace clear obligations about testing, compliance, quality and records.

Limitations of liability need careful treatment. A supplier may try to cap its liability at the value of the last order. For a skincare brand, that may not cover a recall, retailer penalties, wasted marketing spend or damage caused by a defective batch. A fair position often separates ordinary commercial losses from higher-risk issues such as IP infringement, confidentiality breaches, data protection breaches, wilful misconduct and product safety failures.

FAQs

Is a white label skincare agreement different from a private label skincare contract?

The terms are often used interchangeably, but there can be a difference in practice. White label usually means selling a supplier's existing product under your brand, while private label may involve more customisation. Your contract should describe the exact arrangement rather than relying on the label.

Who should be the Responsible Person for a UK skincare product?

The Responsible Person may be the manufacturer, the brand owner or a specialist compliance provider, depending on the structure. The key point is that the agreement must name who holds that role for the relevant market and who is responsible for the supporting safety and notification tasks.

Can my manufacturer change the formula without asking me?

Not if your agreement requires written approval for material formula changes. The contract should treat ingredient substitutions, fragrance changes, preservative changes and packaging compatibility changes as controlled changes that may require testing, label updates or claim review.

Do I need evidence for skincare marketing claims?

Yes. Claims should be accurate, capable of substantiation and consistent with the product's cosmetic status. The agreement should say who provides technical evidence and who approves final advertising copy, retailer descriptions and influencer claims.

What happens if a batch needs to be recalled?

Your contract should set out the recall process before there is a crisis. It should cover notification, quarantine, batch records, customer communications, regulator engagement, costs, refunds, replacement stock and insurance.

Key Takeaways

• A white label skincare agreement should combine commercial supply terms with cosmetics-specific obligations for safety, claims, labelling and traceability.
• Formula ownership, exclusivity and branding rights need clear drafting, especially where you fund product development or customise an existing base formula.
• The contract should identify the Responsible Person and allocate tasks for safety assessments, Product Information Files, notifications and label compliance.
• Claims such as clinically proven, natural, barrier repair or acne reducing should not be used unless the evidence supports the way customers will understand them.
• Batch records, quality control processes and recall clauses are essential for managing defective products, adverse reactions and retailer or regulator enquiries.
• Supply terms should cover minimum orders, lead times, ingredient changes, shortages, exit rights and whether you can move production if supply fails.

If you are launching or scaling a skincare brand, Sprintlaw UK's online legal team can help with your white label manufacturing terms, product supply contract, IP and confidentiality clauses, and cosmetics compliance responsibilities. Contact us on 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.